- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Specialises in
- Urology
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Dr Ami Sabharwal completed her medical training at St Bartholomew's and the Royal London Medical School. She completed her Clinical Oncology training in London and Oxford, including a Masters from the University of London. She was appointed as a Clinical Oncology Consultant in Oxford in 2009. She specializes in the treatment of Urological cancers, specifically prostate and bladder cancer, providing radiotherapy, hormonal treatment, chemotherapy and radioisotope treatment. She has a particular interest in technical radiotherapy, stereotactic radiotherapy for the treatment of prostate cancer and cancer metastases, both on the MR linac and on CT based platforms and has a key role in the multidisciplinary team, assessing patients for these treatments. She is research active and has been the Principle Investigator for a number of radiotherapy trials including PivotalBoost.
Areas of interest
Prostate cancer; oligometastatic disease; metastatic disease; MR linac; MR-guided radiotherapy; IMRT; IGRT; hormonal treatment; enzalutamide; abiraterone; radionucleotide treatment; radium-223; Lu-177 PSMA;
Medical secretaries
- Janet white
- 01865 237708
- pa.drSabharwal@genesiscare.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X6772
Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (1-5)
-
X0008
Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (1-5)
-
A1070
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (1-5)